Chronological changes in microRNA expression in the developing human brain. by Michael P Moreau, Shannon E Bruse, Rebecka Jornsten, Yushi Liu, Linda M Brzustowicz

Get full text

Exploring the Partonic Phase at Finite Chemical Potential in and out-of Equilibrium by O. Soloveva, P. Moreau, L. Oliva, V. Voronyuk, V. Kireyeu, T. Song, E. Bratkovskaya

Get full text

Does pre-operative echocardiography delay hip fracture surgery? by Mustansir Alibhai, Aadhar Sharma, Moiz K Alibhai, Ross A Fawdington, A P Moreau

Get full text

LONG-TERM OUTCOMES WITH ISATUXIMAB-CARFILZOMIB-DEXAMETHASONE IN RELAPSED MULTIPLE MYELOMA PATIENTS WITH 1Q21+ STATUS: UPDATED RESULTS FROM THE PHASE 3 IKEMA STUDY by E Crusoe, T Facon, P Moreau, I Spicka, K Suzuki, K Yong, J Mikhael, T Fukao, N Armstrong, T Martin

Get full text

Validation of a microRNA target site polymorphism in H3F3B that is potentially associated with a broad schizophrenia phenotype. by William Manley, Michael P Moreau, Marco Azaro, Stephen K Siecinski, Gillian Davis, Steven Buyske, Veronica Vieland, Anne S Bassett, Linda Brzustowicz

Get full text

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABE... by A. Maiolino, P. Moreau, M. Dimopoulos, J. Mikhael, K. Yong, M. Capra, T. Facon, R. Hajek, I. Spicka, M. Risse, G. Asset, S. Macé, T. Martin

Get full text

Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-lab... by M. Turgut, P. Moreau, M. Dimopoulos, J. Mikhael, K. Yong, M. Capra, T. Facon, R. Hajek, I. Spicka, M. Risse, G. Asset, S. Macé, T. Martin

Get full text

ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS by A Maiolino, R Hajek, T Jelinek, P Moreau, T Martin, L Pour, G Mikala, A Symeonidis, S Bringhen, A Rawlings, ML Risse, H Vande-Velde, I Spicka

Get full text

P24: EXPERT PERSPECTIVES OF UNMET NEED IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) WHO RECEIVE LENALIDOMIDE-SPARING REGIMENS IN EUROPE by M Mateos, X Leleu, E Zamagni, M Delforge, S Bringhen, A Broijl, J de la Rubia, A Shaw, A Brescianini, S Gonzalez-McQuire, S Patel, P Moreau

Get full text

S176: DARATUMUMAB CARFILZOMIB LENALIDOMIDE AND DEXAMETHASONE AS INDUCTION THERAPY IN HIGH-RISK TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: RESULTS OF THE PHASE 2 STUDY IF... by C. Touzeau, A. Perrrot, C. Hulin, S. Manier, M. Macro, M.-L. Chretien, L. Karlin, O. Decaux, C. Jacquet, M. Tiab, X. Leleu, L. Planchce, H. Avet-Loiseau, P. Moreau

Get full text

P10 AN ULTRA-SENSITIVE METHOD FOR SEQUENCING AND MONITORING OF M-PROTEIN IN PERIPHERAL BLOOD (M-INSIGHT) by V. Bonifay, V. Vimard, S. Noori, C. Wijnands, C. Touzeau, J. Corre, A. Perrot, P. Moreau, H. Caillon, T. Dejoie, T. Luider, M. VanDuijn, J. Jacobs, A. Van Gool, P. Sonigo

Get full text

B04 IMPLEMENTING M-PROTEIN DIAGNOSTICS IN MULTIPLE MYELOMA PATIENTS USING ULTRA-SENSITIVE TARGETED MASS SPECTROMETRY DATA AND AN OFF-THE-SHELF CALIBRATOR by C. Wijnands, P. Langerhorst, S. Noori, J. Gloerich, V. Bonifay, C. Touzeau, J. Corre, A. Perrot, P. Moreau, H. Caillon, T. Luider, A. van Gool, T. Dejoie, M. VanDuijn, J. Jacobs

Get full text

P972: INDIRECT COMPARISON OF TECLISTIMAB IN MAJESTEC-1 VERSUS PHYSICIAN’S CHOICE OF THERAPY IN LONG-TERM FOLLOW-UP OF TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA IN D... by K. Weisel, A. Chari, S. Z. Usmani, H. Goldschmidt, M.-V. Mateos, K. Qi, A. Londhe, S. Nair, X. Lin, L. Pei, E. Ammann, R. Kobos, J. Smit, T. Parekh, M. Slavcev, P. Moreau

Get full text

P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS... by D. Kuter, H. Goldschmidt, D. Cella, M. T. Petrucci, P. Moreau, B. Durie, A. Juarez-Garcia, L. Trong, J. Gu, G. Hernandez Rivera, S. Dhanasiri, T. Marshall, J. Wang, L. Lacoin, K. Ramasamy, R. Vij

Get full text

P935: REAL WORLD COMPARATIVE ANALYSIS OF THE EFFICACY OF TECLISTAMAB VERSUS CURRENT TREATMENTS IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM THE L... by H. Einsele, P. Moreau, M. Delforge, N. W. van de Donk, F. Ghilotti, J. Diels, A. Elsada, V. Strulev, L. Pei, R. Kobos, J. Smit, M. Slavcev, K. Weisel, M.-V. Mateos

Get full text

Thermal loads in gaps between ITER divertor monoblocks: First lessons learnt from WEST by J.P. Gunn, J. Bucalossi, Y. Corre, M. Diez, E. Delmas, N. Fedorczak, A. Grosjean, M. Firdaouss, J. Gaspar, T. Loarer, M. Missirlian, P. Moreau, E. Nardon, C. Reux, M. Richou, E. Tsitrone

Get full text

Expressed fusion gene landscape and its impact in multiple myeloma by A. Cleynen, R. Szalat, M. Kemal Samur, S. Robiou du Pont, L. Buisson, E. Boyle, M. L. Chretien, K. Anderson, S. Minvielle, P. Moreau, M. Attal, G. Parmigiani, J. Corre, N. Munshi, H. Avet-Loiseau

Get full text

P945: SUBCUTANEOUS ISATUXIMAB ADMINISTRATION BY AN ON-BODY DELIVERY SYSTEM IN COMBINATION WITH POMALIDOMIDE-DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: INTERIM... by H. Quach, G. Parmar, E. M. Ocio, H. M. Prince, A. Oriol, N. Tsukada, K. Sunami, P. Bories, C. Karanes, S. Madan, D. Semiond, M. Inchauspe, S. Macé, P. B. Musholt, F. Suzan, P. Moreau

Get full text

Emissivity measurement of the ITER-like plasma facing components of the WEST phase 2: Pre-exposure measurements and first WEST exposure by J. Gaspar, F. Rigollet, N. Ehret, Y. Anquetin, E. Bernard, Y. Corre, M. Diez, M. Firdaouss, M. Houry, T. Loarer, C. Martin, M. Missirlian, P. Moreau, C. Pocheau, P. Reihlac, M. Richou, E. Tsitrone

Get full text

ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS by M.E.Z. Capra, M. Beksac, P.G. Richardson, A. Unal, P. Corradini, S. Delimpasi, Z. Gulbas, G. Mikala, A. Neylon, A. Symeonidis, S. Bringhen, P. Moreau, H.V. Velde, F. Campana, S.L. Guennec, I. Spicka

Get full text